Evolv Technologies (NASDAQ:EVLV) Posts Earnings Results

Evolv Technologies (NASDAQ:EVLV) released its quarterly earnings results on Tuesday. The company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.14, Zacks reports. Evolv Technologies had a negative net margin of 43.76% and a negative return on equity of 55.11%. The business had revenue of $38.50 million for the quarter, compared to the consensus estimate of $36.44 million.

Here are the key takeaways from Evolv Technologies’ conference call:

• Raised 2026 outlook — management increased full-year revenue guidance to $172–$178M, expects ARR of $145–$150M (20–25% growth), plans to exceed 10,000 deployed units, and targets high-single-digit adjusted EBITDA margins.
• Strong 2025 results — Q4 revenue was $38.5M (+32% YoY), full-year revenue $145.9M (+40% YoY), ARR $120.5M (+21% YoY), RPO $293.4M, and ~8,000 systems deployed screening millions daily.
• Business model shift to direct fulfillment — bringing purchase subscriptions in-house is increasing captured revenue, ARR and RPO over time but caused a near-term adjusted gross margin headwind and a ~$1M one-time service accrual.
• Product and market traction — early demand for the eXpedite autonomous bag-screening product (65 customers) plus continued Gen 2 upgrades, new wins across education, healthcare, sports, and a preferred-provider designation with the American Hospital Association support expansion.
• Improving profitability and cash — fifth consecutive quarter of positive adjusted EBITDA (2025 adjusted EBITDA $11.1M vs. a $21M loss in 2024), cash and marketable securities rose to $69M, and management expects to be cash-flow positive in H2 2026.

Evolv Technologies Stock Up 0.5%

Shares of NASDAQ:EVLV traded up $0.03 during trading on Wednesday, hitting $5.28. The company’s stock had a trading volume of 3,976,916 shares, compared to its average volume of 2,774,494. The company has a market capitalization of $921.12 million, a PE ratio of -14.17 and a beta of 1.89. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.20 and a current ratio of 1.27. Evolv Technologies has a fifty-two week low of $2.64 and a fifty-two week high of $8.91. The business has a 50 day moving average price of $5.99 and a two-hundred day moving average price of $6.91.

Insider Transactions at Evolv Technologies

In related news, Director Michael Ellenbogen sold 91,771 shares of the business’s stock in a transaction on Friday, March 6th. The stock was sold at an average price of $5.10, for a total transaction of $468,032.10. Following the completion of the transaction, the director directly owned 2,083,961 shares of the company’s stock, valued at $10,628,201.10. The trade was a 4.22% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders sold 253,261 shares of company stock valued at $1,410,326 in the last ninety days. Company insiders own 11.30% of the company’s stock.

Institutional Investors Weigh In On Evolv Technologies

A number of hedge funds have recently bought and sold shares of the stock. CW Advisors LLC boosted its stake in shares of Evolv Technologies by 19.0% in the 2nd quarter. CW Advisors LLC now owns 12,614 shares of the company’s stock valued at $79,000 after buying an additional 2,014 shares during the period. Victory Capital Management Inc. increased its stake in shares of Evolv Technologies by 16.5% during the third quarter. Victory Capital Management Inc. now owns 15,601 shares of the company’s stock worth $118,000 after buying an additional 2,206 shares during the period. Advisory Services Network LLC raised its holdings in Evolv Technologies by 13.2% in the fourth quarter. Advisory Services Network LLC now owns 22,694 shares of the company’s stock valued at $162,000 after acquiring an additional 2,651 shares in the last quarter. BNP Paribas Financial Markets raised its holdings in Evolv Technologies by 38.3% in the second quarter. BNP Paribas Financial Markets now owns 12,985 shares of the company’s stock valued at $81,000 after acquiring an additional 3,596 shares in the last quarter. Finally, IFC & Insurance Marketing Inc. purchased a new position in Evolv Technologies in the fourth quarter worth approximately $28,000. Institutional investors and hedge funds own 66.65% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on EVLV. Lake Street Capital lifted their target price on shares of Evolv Technologies from $9.00 to $10.00 and gave the company a “buy” rating in a report on Friday, November 14th. Weiss Ratings restated a “sell (d-)” rating on shares of Evolv Technologies in a research report on Thursday, January 22nd. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $9.13.

Trending Headlines about Evolv Technologies

Here are the key news stories impacting Evolv Technologies this week:

• Positive Sentiment: Beat on Q4 revenue and earnings — Evolv reported Q4 revenue above consensus and topped EPS estimates, signaling improving operating performance and helping lift investor sentiment. Earnings Beat
• Positive Sentiment: Raised FY‑2026 revenue guidance and accelerating ARR — Management lifted 2026 revenue guidance to the top of its range (~$178M) and highlighted accelerating ARR growth, a direct bullish catalyst because guidance exceeds Street revenue expectations. Guidance Raise
• Neutral Sentiment: Investor Day set for June 9, 2026 — Management scheduled an Investor Day, which could provide more detail on margin improvement, ARR cadence and product adoption; useful but outcome‑dependent. Investor Day
• Neutral Sentiment: Earnings call transcript available — The full Q4/2025 call provides color on bookings, ARR, gross margins and timing of larger deployments; read the transcript for management’s cadence and risks. Earnings Transcript
• Neutral Sentiment: Analyst / market coverage and “mixed” commentary — Post‑report coverage highlights improvements but also calls out negative margin metrics and execution items to watch; the headline beats/guidance are the immediate drivers. Mixed Q4 Details
• Negative Sentiment: Insider selling by a director — Director Michael Ellenbogen sold substantial blocks of shares (multiple transactions totalling nine‑figure notional over time), which can be perceived negatively by investors despite his retained stake. Insider Sale

Evolv Technologies Company Profile

Evolv Technologies, Inc is a publicly traded American security technology company that develops and markets AI-driven weapons detection and screening solutions. The company’s proprietary platform combines advanced sensors, computer vision software and machine learning algorithms to identify potential threats—such as firearms and knives—while minimizing false positives and preserving high throughput. Evolv’s systems are designed to replace or supplement traditional metal detectors and manual bag checks in high-traffic venues.

The company’s flagship product, Evolv Express, integrates seamlessly into existing security checkpoints, allowing guests to pass through without stopping or emptying their pockets.